[1] |
Jenkins HE, Tolman AW, Yuen CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet, 2014, 383(9928):1572-1579. doi: 10.1016/S0140-6736(14)60195-1.
doi: 10.1016/S0140-6736(14)60195-1
pmid: 24671080
|
[2] |
Jenkins HE, Yuen CM. The burden of multidrug-resistant tuberculosis in children. Int J Tubere Lung Dis, 2018, 22(5):3-6. doi: 10.5588/ijtld.17.0357.
doi: 10.5588/ijtld.17.0357
|
[3] |
Dodd PJ, Sismanidis C, Seddon JA. Global burden of drug resistant tuberculosis in children: a mathematical modeling study. Lancet Infect Dis, 2016, 16(10):1193-1201. doi: 10.1016/S1473-3099(16)30132-3.
doi: 10.1016/S1473-3099(16)30132-3
URL
|
[4] |
Song WM, Li YF, Liu YX, et al. Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis. Front Public Health, 2021, 9:721817. doi: 10.3389/fpubh.2021.721817.
doi: 10.3389/fpubh.2021.721817
|
[5] |
World Health Organization. Global tuberculosis report 2021. Gevena: World Health Organization, 2021.
|
[6] |
Jiao WW, Liu ZG, Han R, et al. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Tuberculosis (Edinb), 2015, 95(3): 315-320. doi: 10.1016/j.tube.2015.02.041.
doi: 10.1016/j.tube.2015.02.041
URL
|
[7] |
Tao NN, He XC, Zhang XX, et al. Drug-Resistant Tuberculosis among Children, China, 2006-2015. Emerg Infect Dis, 2017, 23(11):1800-1805. doi: 10.3201/eid2311.170234.
doi: 10.3201/eid2311.170234
URL
|
[8] |
Wang T, Dong F, Li QJ, et al. Clinical and Drug Resistance Characteristics of New Pediatric Tuberculosis Cases in Northern China. Microb Drug Resis, 2018, 24(9):1397-1403. doi: 10.1089/mdr.2017.0382.
doi: 10.1089/mdr.2017.0382
URL
|
[9] |
Xu YH, Li QF, Zhu M, et al. The epidemiological characteristics and profile of drug-resistant tuberculosis among children with tuberculosis in Sichuan, China, 2015-2018: A retrospective study. Medicine, 2020, 99(43):e22608. doi: 10.1097/MD.0000000000022608.
doi: 10.1097/MD.0000000000022608
|
[10] |
World Health Organization. Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children, WHO Policy update. Geneva: World Health Organization, 2014.
|
[11] |
World Health Organization. WHO Meeting Report of a Technical Expert Consultation:Non-inferiority analysis of Xpert MTB/RIF Ultra compared to Xpert MTB/RIF. Geneva: World Health Organization, 2017.
|
[12] |
Horne DJ, Kohli M, Zifodya JS, et al. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Database Syst Rev, 2019, 6:CD009593. doi: 10.1002/14651858.CD009593.pub4.
doi: 10.1002/14651858.CD009593.pub4
|
[13] |
Wsttal C, Raveendran R. Newer Diagnostic Tests and their Application in Pediatric TB. Indian J Pediatr, 2019, 86(5):441-447. doi: 10.1007/s12098-018-2811-0.
doi: 10.1007/s12098-018-2811-0
pmid: 30628039
|
[14] |
吕纯阳, 罗晶晶, 石华, 等. 儿童结核病的实验室诊断现状与进展. 中国防痨杂志, 2020, 42(2):178-184. doi: 10.3969/j.issn.1000-6621.2020.02.018.
doi: 10.3969/j.issn.1000-6621.2020.02.018
|
[15] |
焦伟伟. 儿童结核病分子生物学诊断方法研究进展. 结核与肺部疾病杂志, 2021, 2(1):69-72. doi: 10.3969/j.issn.2096-8493.2021.01.015.
doi: 10.3969/j.issn.2096-8493.2021.01.015
|
[16] |
Schaaf HS, Garcis-Prats AJ, Hesseling AC, et al. Managing multidrug-resistant tuberculosis in children: review of recent developments. Curr Opin Infect Dis, 2014, 27(3):211-219. doi: 10.1097/QCO.0000000000000062.
doi: 10.1097/QCO.0000000000000062
pmid: 24751893
|
[17] |
杨丹丹, 陈军华. 儿童耐药结核病诊治进展. 国际儿科学杂志, 2022, 49(2):109-113. doi: 10.3760/cma.j.issn.1673-4408.2022.02.009.
doi: 10.3760/cma.j.issn.1673-4408.2022.02.009
|
[18] |
Sun Y, Gao L, Xia H, et al. Accuracy of molecular diagnostic tests for drug resistant tuberculosis detection in China: a systematic review. Int J Tuberc Lung Dis, 2019, 23(8):931-942. doi: 10.5588/ijtld.18.0550.
doi: 10.5588/ijtld.18.0550
pmid: 31533884
|
[19] |
邓建军, 肖国光, 万朝敏, 等. 基因芯片技术与涂片培养技术对诊断儿童结核病的比较研究. 四川大学学报(医学版), 2013, 44(3):429-431. doi: 10.13464/j.scuxbyxb.2013.03.006.
doi: 10.13464/j.scuxbyxb.2013.03.006
|
[20] |
焦伟伟, 申阿东. 儿童结核病药物治疗现状及进展. 中华实用儿科临床杂志, 2020, 5(35):753-758. doi: 10.3760/cmn.j.cn101070-20200525-00883.
doi: 10.3760/cmn.j.cn101070-20200525-00883
|
[21] |
World Health Organization. WHO treatment guidelines for multidrug and rifampicin resistant tuberculosis,2018 update. Geneva: World Health Organization, 2018:17-23.
|